Genetic products maker Affymetrix Inc (AFFX) has announced the launch of its GeneChip miRNA 2.0 array, an extended version of its coveted first-generation microRNA/miRNA (a small RNA molecule) array solution. The new array has been geared to advance gene expression research by expediting the identification of biomarkers and gene expression signatures associated with disease.

The GeneChip miRNA 2.0 array offers similar benefits of the legacy miRNA array with updated content and high sensitivity, reproducibility and performance. It covers the broadest spectrum of miRNA encompassing 131 organisms on a single array.

The new array, with nearly double the content of its predecessor, offers the most sensitive, accurate and comprehensive measurement of miRNA transcripts involved in gene regulation. This affordable array is compatible with the company’s existing GeneChip systems. The miRNAs discovered using GeneChip miRNA 2.0 can be validated using the upcoming QuantiGene 2.0 miRNA assay kit.

California-based Affymetrix is a leading provider of microarray-based products and services to the global research community. Along with Illumina Inc. (ILMN), it is one of the two major providers of microarray technologies primarily used in the field of genetic research.

Affymetrix has expertise in gene expression monitoring arrays, which are used to identify correlations between genes, determine their biological functions and identify patterns that enable more accurate disease classification. 

Affymetrix is expanding its customer base through new product introductions and strategic alliances. The company’s Axiom array platform (launched in October 2009) has been a key driver for its DNA business, representing roughly 40% of total volumes in fourth-quarter fiscal 2010, boosted by healthy customer demand.

To broaden its Axiom platform, Affymetrix launched the Axiom Custom Genotyping Arrays in July 2010, enabling it to address the latest trends in genetic research. Moreover, in January 2011, the company launched its first high-density rice genotyping test dubbed GeneChip Rice 44K SNP Genotyping Array for identifying rice varieties and exploring genetic traits.

Affymetrix continues to enjoy steady end-user demand for its arrays as evidenced by sustained volume growth over the past few quarters. However, the company remains challenged by a soft operating backdrop in Europe and competitive product offerings that leverage advanced technologies.

 
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
 
ILLUMINA INC (ILMN): Free Stock Analysis Report
 
Zacks Investment Research